l-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson’s disease

[1]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[2]  H. E. Rosvold,et al.  Behavioral effects of selective ablation of the caudate nucleus. , 1967, Journal of comparative and physiological psychology.

[3]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[4]  O. Hornykiewicz The mechanisms of action of L-dopa in Parkinson's disease. , 1974, Life sciences.

[5]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[6]  A Carlsson,et al.  Antipsychotic drugs, neurotransmitters, and schizophrenia. , 1978, The American journal of psychiatry.

[7]  H. E. Rosvold,et al.  Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.

[8]  M. Horstink,et al.  Cognitive and motor shifting aptitude disorder in Parkinson's disease. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[9]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[10]  C. Marsden,et al.  Recent Developments in Parkinson's Disease , 1986 .

[11]  J. Saint-Cyr,et al.  Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. , 1986, Brain : a journal of neurology.

[12]  D. C. Howell Statistical Methods for Psychology , 1987 .

[13]  S. Fahn Unified Parkinson's Disease Rating Scale , 1987 .

[14]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.

[15]  C. Marsden,et al.  Internal versus external cues and the control of attention in Parkinson's disease. , 1988, Brain : a journal of neurology.

[16]  C. Marsden,et al.  'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. , 1988, Brain : a journal of neurology.

[17]  T. Robbins,et al.  Limbic-striatal interactions in reward-related processes , 1989, Neuroscience & Biobehavioral Reviews.

[18]  P. Goldman-Rakic Dopamine-mediated mechanisms of the prefrontal cortex , 1992 .

[19]  W. Schultz,et al.  Neuronal activity in monkey ventral striatum related to the expectation of reward , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  C. Gerfen D1 and D2 dopamine receptor regulation of striatonigral and striatopallidal neurons , 1992 .

[21]  Y Agid,et al.  Are dopaminergic neurons selectively vulnerable to Parkinson's disease? , 1993, Advances in neurology.

[22]  A. Damasio,et al.  Insensitivity to future consequences following damage to human prefrontal cortex , 1994, Cognition.

[23]  A. Cools,et al.  Card sorting performance in Parkinson's Disease: a comparison between acquisition and shifting performance. , 1995, Journal of clinical and experimental neuropsychology.

[24]  P. Goldman-Rakic,et al.  Modulation of memory fields by dopamine Dl receptors in prefrontal cortex , 1995, Nature.

[25]  S. Monsell,et al.  Costs of a predictible switch between simple cognitive tasks. , 1995 .

[26]  Adrian M. Owen,et al.  Dopamine-Dependent Frontostriatal Planning Deficits in Early Parkinson's Disease , 1995 .

[27]  M. Naoi,et al.  The metabolism of l-DOPA and l-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients , 1996, Journal of the Neurological Sciences.

[28]  Alan C. Evans,et al.  Planning and Spatial Working Memory: a Positron Emission Tomography Study in Humans , 1996, The European journal of neuroscience.

[29]  T. Robbins,et al.  Dissociation in prefrontal cortex of affective and attentional shifts , 1996, Nature.

[30]  N. Meiran Reconfiguration of processing mode prior to task performance. , 1996 .

[31]  T. Robbins,et al.  Doubly dissociable effects of median- and dorsal-raphé lesions on the performance of the five-choice serial reaction time test of attention in rats , 1997, Behavioural Brain Research.

[32]  JaneR . Taylor,et al.  Supranormal Stimulation of D1 Dopamine Receptors in the Rodent Prefrontal Cortex Impairs Spatial Working Memory Performance , 1997, The Journal of Neuroscience.

[33]  Barry J. Everitt,et al.  Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms , 1997, Psychopharmacology.

[34]  M. Millan,et al.  Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo , 1998, Neuropharmacology.

[35]  H. Damasio,et al.  Dissociation Of Working Memory from Decision Making within the Human Prefrontal Cortex , 1998, The Journal of Neuroscience.

[36]  J. Hollerman,et al.  Dopamine neurons report an error in the temporal prediction of reward during learning , 1998, Nature Neuroscience.

[37]  A. Arnsten Catecholamine modulation of prefrontal cortical cognitive function , 1998, Trends in Cognitive Sciences.

[38]  D F Stegeman,et al.  Reliance on external cues for movement initiation in Parkinson's disease. Evidence from movement-related potentials. , 1998, Brain : a journal of neurology.

[39]  S. Keele,et al.  Toward a Functional Analysis of the Basal Ganglia , 1998, Journal of Cognitive Neuroscience.

[40]  Edmund T. Rolls,et al.  The functions of the orbitofrontal cortex , 1999 .

[41]  T. Robbins,et al.  Specific cognitive deficits in mild frontal variant frontotemporal dementia. , 1999, Brain : a journal of neurology.

[42]  T. Robbins,et al.  Dissociable Deficits in the Decision-Making Cognition of Chronic Amphetamine Abusers, Opiate Abusers, Patients with Focal Damage to Prefrontal Cortex, and Tryptophan-Depleted Normal Volunteers: Evidence for Monoaminergic Mechanisms , 1999, Neuropsychopharmacology.

[43]  D. Stein,et al.  Pathological gambling behaviour: Emergence secondary to treatment of Parkinson's disease with dopaminergic agents , 2000, Depression and anxiety.

[44]  B. Sahakian,et al.  Deficits in decision-making in patients with aneurysms of the anterior communicating artery. , 2000, Brain : a journal of neurology.

[45]  F. Chollet,et al.  Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. , 2000, Brain : a journal of neurology.

[46]  F. Jiménez-Jiménez,et al.  Pathologic gambling in Parkinson's disease: A behavioral manifestation of pharmacologic treatment? , 2000, Movement disorders : official journal of the Movement Disorder Society.

[47]  H. Damasio,et al.  Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. , 2000, Brain : a journal of neurology.

[48]  A. Damasio,et al.  Emotion, decision making and the orbitofrontal cortex. , 2000, Cerebral cortex.

[49]  J. Hollerman,et al.  Reward processing in primate orbitofrontal cortex and basal ganglia. , 2000, Cerebral cortex.

[50]  P. Goldman-Rakic,et al.  Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. , 2000, Science.

[51]  S. Mobini,et al.  Effects of central 5-hydroxytryptamine depletion on sensitivity to delayed and probabilistic reinforcement , 2000, Psychopharmacology.

[52]  R. D Rogers,et al.  Impaired planning but intact decision making in early Huntington’s disease: implications for specific fronto-striatal pathology , 2000, Neuropsychologia.

[53]  T. Robbins,et al.  Probabilistic learning and reversal deficits in patients with Parkinson’s disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication , 2000, Neuropsychologia.

[54]  John R. Anderson,et al.  The role of prefrontal cortex and posterior parietal cortex in task switching. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[55]  L. Nystrom,et al.  Tracking the hemodynamic responses to reward and punishment in the striatum. , 2000, Journal of neurophysiology.

[56]  E. Siemers,et al.  Risky decision making in Huntington's disease , 2001, Journal of the International Neuropsychological Society.

[57]  M. Schwaiger,et al.  Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. , 2001, Brain : a journal of neurology.

[58]  A. Smit,et al.  Synapse Formation between Central Neurons Requires Postsynaptic Expression of the MEN1 Tumor Suppressor Gene , 2001, The Journal of Neuroscience.

[59]  T. Robbins,et al.  Decision making and neuropsychiatry , 2001, Trends in Cognitive Sciences.

[60]  T. Robbins,et al.  Impulsive Choice Induced in Rats by Lesions of the Nucleus Accumbens Core , 2001, Science.

[61]  T. Robbins,et al.  Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. , 2001, Cerebral cortex.

[62]  Brian Knutson,et al.  Anticipation of Increasing Monetary Reward Selectively Recruits Nucleus Accumbens , 2001, The Journal of Neuroscience.

[63]  U. Gschwandtner,et al.  Pathologic gambling in patients with Parkinson's disease. , 2001, Clinical neuropharmacology.

[64]  T. Robbins,et al.  Decision making deficits in patients with first-episode and chronic schizophrenia , 2002, Schizophrenia Research.

[65]  Daniel Tranel,et al.  Asymmetric Functional Roles of Right and Left Ventromedial Prefrontal Cortices in Social Conduct, Decision-Making, and Emotional Processing , 2002, Cortex.

[66]  T. Robbins,et al.  Double dissociation of serotonergic and dopaminergic mechanisms on attentional performance using a rodent five-choice reaction time task , 2002, Psychopharmacology.

[67]  T. Robbins,et al.  Decision-making processes following damage to the prefrontal cortex. , 2002, Brain : a journal of neurology.

[68]  P. Jenner,et al.  Pharmacology of dopamine agonists in the treatment of Parkinson’s disease , 2002, Neurology.

[69]  E. Sonuga-Barke,et al.  Psychological heterogeneity in AD/HD—a dual pathway model of behaviour and cognition , 2002, Behavioural Brain Research.

[70]  F. Castellanos,et al.  Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes , 2002, Nature Reviews Neuroscience.

[71]  T. Robbins,et al.  Defining the Neural Mechanisms of Probabilistic Reversal Learning Using Event-Related Functional Magnetic Resonance Imaging , 2002, The Journal of Neuroscience.

[72]  Dawn M Eagle,et al.  Deficits in Impulse Control Associated with Tonically-elevated Serotonergic Function in Rat Prefrontal Cortex , 2002, Neuropsychopharmacology.

[73]  L. Wilkins January 8 Highlights , 2002, Neurology.

[74]  G. McCarthy,et al.  Dissociable prefrontal brain systems for attention and emotion , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[75]  B. Dubois,et al.  Motivation, reward, and Parkinson’s disease: influence of dopatherapy , 2002, Neuropsychologia.

[76]  Antoine Bechara,et al.  Risky Business: Emotion, Decision-Making, and Addiction , 2004, Journal of Gambling Studies.

[77]  M. Mishkin,et al.  Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity , 1970, Experimental Brain Research.

[78]  T. Robbins,et al.  Risk taking during decision-making in normal volunteers changes with age , 2004, Journal of the International Neuropsychological Society.